Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury
Podocyte injury is an independent risk factor for the progression of renal diseases. Semaphorin3A (SEMA3A), expressed in podocytes and tubular cells in the mammalian adult kidneys, has been reported to regulate diverse biological functions and be associated with renal diseases. Here, we investigated...
Main Authors: | Yizhen Sang, Kenji Tsuji, Akiko Inoue-Torii, Kazuhiko Fukushima, Shinji Kitamura, Jun Wada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/11/4099 |
Similar Items
-
Role of Semaphorin 3A in Kidney Development and Diseases
by: Yizhen Sang, et al.
Published: (2023-09-01) -
Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin
by: Mohammed Alquraishi, et al.
Published: (2022-05-01) -
Fyn‐binding protein ADAP supports actin organization in podocytes
by: Zhenzhen Wu, et al.
Published: (2017-12-01) -
Nonimmunologic targets of immunosuppressive agents in podocytes
by: Tae-Hyun Yoo, et al.
Published: (2015-06-01) -
The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
by: Inoue-Torii A, et al.
Published: (2017-06-01)